Michael Egan, Executive Director at Merck, to Present at CNS Diseases World Summit 2016
Summary
Boston, MA, July 21, 2016 --( This meeting provides an interactive learning and relationship-building forum for all players in the CNS field.Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures.CNS Perspectives: Venture Capital and Public Markets For more information, please visit website: www.gtcbio.com/conferences/cns-diseases-world-summit-overview GTCbio 635 W. Foothill Blvd Monrovia, CA 91016 www.gtcbio.com Email: infogtcbio@gtcbio.com Phone: (626) 256-6405 Fax: (626) 466-4433 Boston, MA, July 21, 2016 --( PR.com )-- Michael Egan, Executive Director of Clinical Neuroscience at Merck, will give a featured presentation at GTCbio’s CNS Diseases World Summit 2016 to be held on September 12-15, 2016 in Boston, MA.This meeting provides an interactive learning and relationship-building forum for all players in the CNS field.Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures.The program will provide a comprehensive look at the current state of CNS, from research to commercialization.Monrovia, CA 91016 Fax: 626-466-4433 Click here to view the list of recent Press Releases from GTCbio